Dismal prognosis for cirrhotic patients with hepatitis C after initial failure of direct acting anti-virals, but salvage therapy may be life-saving

Johan Westina Department of Infectious Diseases, Insitute of Biomedicine, University of Gothenburg, Gothenburg, Sweden;b Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, SwedenCorrespondence[email protected]

https://orcid.org/0000-0002-2064-073X View further author information

Magdalena Ydreborga Department of Infectious Diseases, Insitute of Biomedicine, University of Gothenburg, Gothenburg, Sweden;b Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, SwedenView further author information

Christian Kampmannc Department of Infectious Diseases, Skåne University Hospital, Lund, SwedenView further author information

Rune Wejståla Department of Infectious Diseases, Insitute of Biomedicine, University of Gothenburg, Gothenburg, Sweden;b Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, SwedenView further author information

Ola Weilandd Department of Medicine, Division of Infectious Diseases, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, SwedenView further author information

Dismal prognosis for cirrhotic patients with hepatitis C after initial failure of direct acting anti-virals, but salvage therapy may be life-saving

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Dismal prognosis for cirrhotic patients with hepatitis C after initial failure of direct acting anti-virals, but salvage therapy may be life-saving

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date